Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19Jerald Sadoff, Macaya Douoguih, Frank Struyf et al.|New England Journal of Medicine|2021Cited by 2.6k
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H. Barouch, Ludo Lavreys, Frank Tomaka et al.|The Lancet|2018Cited by 342
International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsDan H. Barouch, Jaap Goudsmit, Sandra V. Kik et al.|Vaccine|2011Cited by 308
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.SJerald Sadoff, Macaya Douoguih, Glenda Gray et al.|New England Journal of Medicine|2022Cited by 250
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meetingBoris Jülg, Bruce D. Walker, Lynda Dee et al.|The Lancet HIV|2019Cited by 206